Apr 02, 2020
Reducing Risk of Infection: BlueWillow Biologics to Launch NanoBio® Protect OTC Nasal Antiseptic Solution
Apr 02, 2020
RemeGen Completes USD $100 Million Plus in Funding
Apr 01, 2020
Global Biosimilars Market (2020 to 2025) - New Indications and the Patent Expiry of Biologic Products Present Lucrative Opportunities
Apr 01, 2020
Unchained Labs jumps into gene therapy and vaccines with new AAV stability application!
Mar 31, 2020
Coronavirus (COVID-19) Update: FDA Continues to Accelerate Development of Novel Therapies for COVID-19
Mar 31, 2020
LakePharma Provides Recombinant COVID-19 Proteins to Facilitate Antibody And Diagnostic Development Against COVID-19
Mar 31, 2020
3SBio Unveils 2019 Annual Results: Revenue Rises by 16.0%, Normalized Net Profit attributable to owners of the parent Jumps by19.4%, R&D Expenses Soar 45.2%
Mar 30, 2020
Global Antibody Contract Manufacturing Market (2020 to 2030)
Mar 30, 2020
Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
Mar 27, 2020
Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept
Mar 26, 2020
European Medicines Agency Accepts Arvelle Therapeutics' Marketing Authorization Application for Cenobamate for the Adjunctive Treatment of Focal-Onset Seizures in Adults
Mar 26, 2020
WuXi Biologics Achieved Remarkable Results in 2019
Mar 25, 2020
Innovent Biologics Enters into a Collaboration with Alector to Develop and Commercialize Anti-SIRP-alpha Antibody in China
Mar 24, 2020
MaxCyte and Allogene Therapeutics Sign Clinical and Commercial License Agreement to Enable the Advancement of Allogeneic CAR T (AlloCAR T(TM)) Therapies
Mar 24, 2020
Biosimilars Market Worth $35.7 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
Mar 23, 2020
Insulin Gains New Pathway to Increased Competition
Mar 22, 2020
Liminal BioSciences comments on Coronavirus (COVID-19)
Mar 19, 2020
AGC Biologics to Participate in Virtual BIO-Europe Spring
Mar 18, 2020
Exploring Avenues in Personalized Medical Care Defines Advances in Red Biotechnology Market: Valuation to Touch Massive US$512 Bn By 2027, Finds Transparency Market Research
Mar 18, 2020
Visiongain Report: Global Rheumatoid Arthritis Drugs Market Estimated to Grow at a CAGR of 0.6% in the Second Half of the Forecast Period